ArticleSignal transduction and targeted therapy2025

Targeting pathological brain activity-related to neuroinflammation through scRNA-seq for new personalized therapies in Parkinson's disease.

Daniela Mirzac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.